美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA040745"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
83703-545-01 83703-545 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Bamboo US Bidco LCC CYCLOPHOSPHAMIDE 2 g/100mL 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-545-01) / 100 mL in 1 VIAL, SINGLE-DOSE (83703-545-10)
83703-549-01 83703-549 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Bamboo US Bidco LCC CYCLOPHOSPHAMIDE 500 mg/25mL 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-549-01) / 25 mL in 1 VIAL, SINGLE-DOSE (83703-549-25)
10019-936-01 10019-936 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Baxter Healthcare Corporation CYCLOPHOSPHAMIDE 1 g/50mL 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-936-01) / 50 mL in 1 VIAL, SINGLE-DOSE (10019-936-50)
10019-942-01 10019-942 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Baxter Healthcare Corporation CYCLOPHOSPHAMIDE 2 g/100mL 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-942-01) / 100 mL in 1 VIAL, SINGLE-DOSE (10019-942-10)
72572-083-01 72572-083 HUMAN PRESCRIPTION DRUG Cyclophosphamide cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20221214 N/A ANDA ANDA040745 Civica, Inc. CYCLOPHOSPHAMIDE 2 g/100mL 1 VIAL, SINGLE-DOSE in 1 CARTON (72572-083-01) / 100 mL in 1 VIAL, SINGLE-DOSE
10019-956-01 10019-956 HUMAN PRESCRIPTION DRUG Cyclophosphamide cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Baxter Healthcare Corporation CYCLOPHOSPHAMIDE 1 g/50mL 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-956-01) / 50 mL in 1 VIAL, SINGLE-DOSE (10019-956-16)
68001-443-27 68001-443 HUMAN PRESCRIPTION DRUG Cyclophosphamide cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20201019 N/A ANDA ANDA040745 BluePoint Laboratories CYCLOPHOSPHAMIDE 1 g/50mL 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-443-27) / 50 mL in 1 VIAL, SINGLE-DOSE
83703-543-01 83703-543 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Bamboo US Bidco LCC CYCLOPHOSPHAMIDE 500 mg/25mL 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-543-01) / 25 mL in 1 VIAL, SINGLE-DOSE (83703-543-25)
83703-547-01 83703-547 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Bamboo US Bidco LCC CYCLOPHOSPHAMIDE 2 g/100mL 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-547-01) / 100 mL in 1 VIAL, SINGLE-DOSE (83703-547-10)
83703-551-01 83703-551 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Bamboo US Bidco LCC CYCLOPHOSPHAMIDE 2 g/100mL 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-551-01) / 100 mL in 1 VIAL, SINGLE-DOSE (83703-551-10)
10019-938-01 10019-938 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Baxter Healthcare Corporation CYCLOPHOSPHAMIDE 500 mg/25mL 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-938-01) / 25 mL in 1 VIAL, SINGLE-DOSE (10019-938-25)
10019-944-01 10019-944 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Baxter Healthcare Corporation CYCLOPHOSPHAMIDE 1 g/50mL 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-944-01) / 50 mL in 1 VIAL, SINGLE-DOSE (10019-944-50)
72572-087-01 72572-087 HUMAN PRESCRIPTION DRUG Cyclophosphamide cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20221214 N/A ANDA ANDA040745 Civica, Inc. CYCLOPHOSPHAMIDE 500 mg/25mL 1 VIAL, SINGLE-DOSE in 1 CARTON (72572-087-01) / 25 mL in 1 VIAL, SINGLE-DOSE
68001-442-26 68001-442 HUMAN PRESCRIPTION DRUG Cyclophosphamide cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20201019 N/A ANDA ANDA040745 BluePoint Laboratories CYCLOPHOSPHAMIDE 500 mg/25mL 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-442-26) / 25 mL in 1 VIAL, SINGLE-DOSE
83703-546-01 83703-546 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Bamboo US Bidco LCC CYCLOPHOSPHAMIDE 500 mg/25mL 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-546-01) / 25 mL in 1 VIAL, SINGLE-DOSE (83703-546-25)
83703-550-01 83703-550 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Bamboo US Bidco LCC CYCLOPHOSPHAMIDE 1 g/50mL 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-550-01) / 50 mL in 1 VIAL, SINGLE-DOSE (83703-550-50)
10019-937-01 10019-937 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Baxter Healthcare Corporation CYCLOPHOSPHAMIDE 2 g/100mL 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-937-01) / 100 mL in 1 VIAL, SINGLE-DOSE (10019-937-10)
10019-943-01 10019-943 HUMAN PRESCRIPTION DRUG CYCLOPHOSPHAMIDE cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Baxter Healthcare Corporation CYCLOPHOSPHAMIDE 500 mg/25mL 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-943-01) / 25 mL in 1 VIAL, SINGLE-DOSE (10019-943-25)
72572-085-01 72572-085 HUMAN PRESCRIPTION DRUG Cyclophosphamide cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20221214 N/A ANDA ANDA040745 Civica, Inc. CYCLOPHOSPHAMIDE 1 g/50mL 1 VIAL, SINGLE-DOSE in 1 CARTON (72572-085-01) / 50 mL in 1 VIAL, SINGLE-DOSE
10019-957-01 10019-957 HUMAN PRESCRIPTION DRUG Cyclophosphamide cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20080521 N/A ANDA ANDA040745 Baxter Healthcare Corporation CYCLOPHOSPHAMIDE 2 g/100mL 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-957-01) / 100 mL in 1 VIAL, SINGLE-DOSE (10019-957-11)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase